If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
45
Followers on Owler
Overview
Competitors
Funding
News & Insights
Evolus Funding History
Since Evolus was founded in 2012, it has participated in 6 rounds of funding. In total Evolus has raised $372.4M. Evolus' last funding round was on Mar 2024 for a total of $46.9M.
Evolus Funding Rounds
Unlock 3 more funding rounds →
ROUND
FUNDING DATE
AMOUNT
NUMBER OF INVESTORS
INVESTORS
Post-IPO Equity
Mar 2024
$46.9M
__
Post-IPO Debt
Dec 2021
$125M
1
Pharmakon Advisors
Convertible Note
Jul 2020
$40M
1
Daewoong Pharmaceutical
Post-IPO Debt
Mar 2019
$100M
1
Oxford Finance LLC
IPO
Feb 2018
$60M
__
Evolus Investors
INVESTOR
ROUND
FUNDING DATE
Pharmakon Advisors
Post-IPO Debt
Dec 2021
Daewoong Pharmaceutical
Convertible Note
Jul 2020
Oxford Finance LLC
Post-IPO Debt
Mar 2019
Evolus has 3 investors, including Pharmakon Advisors, Daewoong Pharmaceutical and Oxford Finance LLC. The latest investment occurred in Mar 2024.
